Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC60407 (R)-Verapamil D7 hydrochloride

    (R)-(+)-Verapamil D7 hydrochloride

    (R)-VerapamilD7hydrochloride((R)-(+)-VerapamilD7hydrochloride)是(R)-Verapamilhydrochloride的一种氘代化合物。(R)-Verapamilhydrochloride((R)-(+)-Verapamilhydrochloride)是一种P-糖蛋白抑制剂。(R)-Verapamilhydrochloride抑制MRP1介导的转运,导致MRP1过表达细胞对抗癌药产生化学敏感性。
  3. GC60398 (6R)-FR054

    (3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐

    (6R)-FR054是FR054的一个活性异构体。FR054是HBP酶PGM3的抑制剂,具有显著的抗乳腺癌活性。FR054可诱导内质网应激和ROS依赖的细胞凋亡。
  4. GC60397 (5Z,2E)-CU-3 A DGK-α inhibitor
  5. GC60377 Urolithin C

    尿石素C

    UrolithinC,是鞣花酸的多酚类肠道微生物代谢产物,是胰岛素分泌(insulinsecretion)的葡萄糖依赖性激活剂。UrolithinC是一种L型Ca2+通道开放剂,可增强Ca2+的流入。UrolithinC通过线粒体介导的途径诱导细胞凋亡(apoptosis),并刺激活性氧(ROS)的形成。
  6. GC60376 UC2288 UC2288 is a novel, cell-permeable, and orally active p21 attenuator, decreases p21 mRNA expression independently of p53, and attenuates p21 protein levels with minimal effect on p21 protein stability.
  7. GC60364 Thienopyridone Thienopyridone 是一种有效的选择性的肝再生磷酸酶 (PRL) 磷酸酶抑制剂,对于 PRL-1,PRL-2 和 PRL-3,IC50 值分别为 173 nM,277 nM 和 128 nM。Thienopyridone 对其他磷酸酶的影响很小。Thienopyridone 可诱导 p130Cas 裂解和细胞凋亡 (apoptosis),并具有抗癌作用。
  8. GC60352 Taraxerol

    蒲公英萜醇

    Taraxerol 具有抗炎和抗癌作用。
  9. GC60348 Supinoxin

    RX-5902

    Supinoxin (RX-5902) 是磷酸化 p68 RNA 解旋酶 (P-p68) 的强效口服活性抑制剂,并且是一个一流的抗肿瘤试剂 (anti-cancer agent)。Supinoxin 与 Y593 磷酸化的 p68 相互作用并减弱 β-catenin 的核穿梭性。 Supinoxin 诱导细胞凋亡 (apoptosis) 并抑制 TNBC 癌细胞系的生长,IC50 的范围为 10 nM 至 20 nM。
  10. GC60339 SKI V

    2-(3,4-二羟基亚苄基)苯并呋喃-3(2H)-酮

    SKI V is a noncompetitive and potent inhibitor of non-lipid sphingosine kinase with IC50 of 2 μM for GST-hSK. SKI-V also inhibits PI3K with IC50 of 6 μM for hPI3k. SKI-V decreases formation of the mitogenic second messenger sphingosine-1-phosphate (S1P) and induces apoptosis with antitumor activity.
  11. GC60336 SEC SEC通过AMPK/mTORC1/STAT3信号通路诱导ANXA7GTPase的激活。SEC选择性的促进癌细胞的凋亡,诱导ITGB4核转位,表达高水平ITGB4。
  12. GC60325 Rilmenidine

    利美尼啶

    An antihypertensive agent
  13. GC60317 RA-9

    (3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮

    RA-9 is a cell-permeable, potent and selective inhibitor of proteasome-associated deubiquitinating enzymes (DUBs) with favorable toxicity profile and anticancer activity. RA-9 selectively induces apoptosis in ovarian cancer cell lines.
  14. GC60307 PROTAC RIPK degrader-2 PROTAC RIPK degrader-2 是一种非肽性PROTAC,它以丝氨酸苏氨酸激酶 RIPK2 为靶点,对 RIPK2 的降解具有高度选择性。
  15. GC60297 Polyinosinic-polycytidylic acid sodium

    双链聚肌胞; Poly(I:C)

    Polyinosinic-polycytidylic acid sodium (Poly I:C)是一种合成的dsRNA,可以模拟病毒感染,并通过触发特定的模式识别受体(PRRs),如toll样受体3(TLR3)和维甲酸诱导基因I(RIG-I)样受体,包括RIG-I和黑色素瘤分化相关基因5,引发宿主免疫反应。
  16. GC60288 Picrocrocin

    苦番紅花素

    Picrocrocin, the chemical most responsible for the bitter taste of saffron, is isolated from saffron and inhibits proliferation of cancer cells.
  17. GC60283 Pentagamavunon-1

    PGV-1

    Pentagamavunon-1 (PGV-1) 是Curcumin 的类似物,具有口服活性,通过多个机制诱导凋亡信号,如抑制COX-2 和 VEGF。Pentagamavunon-1 (PGV-1) 可抑制 NF-κB 的激活。
  18. GC60278 OT-82 OT-82 is a novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitor with average IC50s of 13.03 ??nM in non-HP cancer cells and 2.89? ?nM in HP cancer cells, respectively.
  19. GC60268 Neoxanthin

    新黄质

    Neoxanthin是深绿色多叶蔬菜中的一种主要的叶黄素类胡萝卜素,是一种植物激素脱落酸的前体。Neoxanthin是一种有效的抗氧化剂和集光颜料,诱导细胞凋亡(apoptosis)并具有抗癌作用。

  20. GC60264 Naphthazarin

    萘茜,DHNQ; 5,8-Dihydroxy-1,4-naphthoquinone

    Naphthazarin(DHNQ)是天然存在的化合物,通过多种细胞机制有效,包括氧化应激,线粒体凋亡诱导因子(AIF)活化,微管解聚,干扰溶酶体功能和p53依赖性p21活化。Naphthazarin触发细胞凋亡(apoptosis)并具有抗肿瘤作用。
  21. GC60259 MYCMI-6

    NSC354961

    MYCMI-6 (NSC354961) 是一种有效的选择性内源性 MYC:MAX 蛋白相互作用抑制剂。 MYCMI-6 阻断 MYC 驱动的转录。MYCMI-6 选择性结合 MYC bHLHZip 域,Kd 值为 1.6 μM。MYCMI-6 以 MYC 依赖性的方式抑制肿瘤细胞的生长 (IC50<0.5 μM)。MYCMI-6 对正常人细胞无细胞毒性。MYCMI-6 诱导细胞凋亡 (apoptosis)。
  22. GC60258 MT 63-78 MT 63-78 是一种有效的直接 AMPK 激活剂,EC50 为 25 μM。M 63-78 还诱导细胞有丝分裂阻滞和细胞凋亡 (apoptosis)。MT 63-78 通过抑制脂肪生成和 mTORC1 途径来阻止前列腺癌的生长。MT 63-78 具有抗肿瘤作用。
  23. GC60241 Melatonin D5

    褪黑素 D5; N-Acetyl-5-methoxytryptamine-d4

    An internal standard for the quantification of melatonin
  24. GC60229 LQZ-7I

    N2,N3-双(4-氟苯基)喹喔啉-2,3-二胺

    An inhibitor of survivin
  25. GC60225 Licarin A

    利卡灵A,(+)-Licarin A

    LicarinA((+)-LicarinA),可从多种植物中分离得到,显着降低二硝基苯肼-人血清白蛋白(DNP-HSA)刺激的RBL-2H3细胞。具有抗过敏作用。LicarinA降低TNF-α和PGD2产生,和COX-2表达。
  26. GC60221 Lactoferrin (17-41) (acetate)

    Lactoferricin B acetate; Lfcin B acetate

    Lactoferrin 17-41 (Lactoferricin B) acetate 对应于牛乳铁蛋白的残基 17-41,对革兰氏阳性和革兰氏阴性细菌、病毒、原生动物和真菌等多种微生物具有抗菌活性。Lactoferrin 17-41 acetate 具有抗肿瘤活性。
  27. GC60173 Ginsenoside F5

    人参皂苷F5

    GinsenosideF5,可从Panaxginseng中提物,通过凋亡(apoptosis)途径显着抑制HL-60细胞生长。
  28. GC60159 Ezetimibe ketone

    (3R,4S)-1-(4-氟苯基)-3-[3-(4-氟苯基)-3-氧代丙基]-4-(4-羟基苯基)氮杂环丁烷-2-酮,EZM-K

    Ezetimibe ketone (EZM-K) 是 Ezetimibe 的 I 期代谢产物。Ezetimibe 是一种 NPC1L1 抑制剂,是有效的 Nrf2 激活剂,Ezetimibe 还是有效的胆固醇吸收抑制剂。
  29. GC60157 Euphorbia Factor L2

    大戟因子L2

    Euphorbia factor L2 是从大戟种子中分离得到的一种赤藓烷二萜 (Euphorbia lathyris L.),传统上用于治疗癌症。Euphorbia factor L2 显示强烈的细胞毒性并通过线粒体途径诱导细胞凋亡。
  30. GC60153 Eriocalyxin B

    毛萼乙素

    EriocalyxinB是从中草药枇杷素中分离得到的一种二萜类化合物。EriocalyxinB具有抗癌、抗炎作用。EriocalyxinB诱导细胞凋亡(apoptosis)。
  31. GC60111 Clitocine

    克力托辛

    Clitocine是一种腺苷核苷类似物,是一种有效的通透剂(readthrough)。Clitocine可诱导携带p53无义突变等位基因的细胞产生p53蛋白。Clitocine可通过靶向Mcl-1诱导多药耐药肿瘤细胞凋亡。具有抗癌活性。
  32. GC60076 Bigelovin

    锦菊素

    Bigelovin是可从海百合中分离得到的一种倍半萜内酯,是选择性的视黄素X受体α(retinoidXreceptorα)的激动剂。Bigelovin可通过诱导凋亡和自噬来发挥抗肿瘤活性。Bigelovin通过抑制ROS的生成来调节mTOR信号通路。
  33. GC60008 (S)-Verapamil hydrochloride

    S-维拉帕米,(S)-(-)-Verapamil hydrochloride

    (S)-Verapamil hydrochloride (S(-)-Verapamil hydrochloride) 通过 MRP1 抑制白三烯 C4 (LTC4) 和钙黄绿素的转运。(S)-Verapamil hydrochloride 导致潜在耐药性肿瘤细胞死亡。
  34. GC18572 Concanavalin A

    刀豆蛋白

    Concanavalin A属于concanamycin,这是一种从异色链霉菌中分离出来的大环内酯类抗生素,是液泡质子- atp酶(v-[H[+]] atp酶)的高活性和选择性抑制剂。
  35. GC18533 ZLDI-8 ZLDI-8 是一种 Notch 激活/切割酶 ADAM-17 抑制剂,可抑制 Notch 蛋白的切割。 ZLDI-8 降低促存活/抗凋亡和上皮间质转化 (EMT) 相关蛋白的表达。 ZLDI-8 还是一种竞争性且不可逆的酪氨酸磷酸酶 (Lyp) 抑制剂,IC50 为 31.6 μM,Ki 为 26.22 μM。 ZLDI-8 抑制 MHCC97-H 细胞的生长,IC50 为 5.32 μM。
  36. GC39827 HM03

    4-((6-氯-2-甲氧基吖啶-9-基)氨基)-2-((4-甲基哌嗪-1-基)甲基)苯酚

    HM03 是一种有效的选择性的热休克 70 kDa 蛋白 5, HSPA5 (也称为 Bip,Grp78) 抑制剂,具有抗肿瘤活性。
  37. GC39820 Lometrexol hydrate

    洛美曲索水合物,DDATHF hydrate

    A GART inhibitor
  38. GC39815 Semapimod tetrahydrochloride

    CNI-1493; CPSI-2364 tetrahydrochloride

    Semapimod tetrahydrochloride (CNI-1493) 是促炎细胞因子产生 (proinflammatory cytokine) 的抑制剂,可抑制TNF-α、IL-1β 和 IL-6。Semapimod tetrahydrochloride 抑制巨噬细胞 p38 MAPK 和一氧化氮生成。Semapimod tetrahydrochloride 抑制 TLR4 信号 (IC50≈0.3 μM)。Semapimod tetrahydrochloride 在多种炎症和自身免疫性疾病中具有潜在的作用。
  39. GC39814 Mitoguazone

    米托瓜酮; Methylglyoxal-bis(guanylhydrazone); MGBG; Methyl-GAG

    Mitoguazone (Methylglyoxal-bis(guanylhydrazone)) 是一种具有有效抗肿瘤活性的合成多羰基衍生物。Mitoguazone 是一种可透过血脑屏障的竞争性的 S-腺苷-蛋氨酸脱羧酶 (S-adenosyl-methionine decarboxylase) 抑制剂,可破坏多胺的生物合成。Mitoguazone 诱导细胞凋亡 (apoptosis),可抑制 HIV DNA 整合到单核细胞和巨噬细胞中的细胞 DNA 中。Mitoguazone 具可用于急性白血病,霍奇金淋巴瘤和非霍奇金淋巴瘤的研究。
  40. GC39808 Didesmethylrocaglamide Didesmethylrocaglamide 是一种 Rocaglamide 的衍生物,也是一种有效的真核起始因子 4A (eIF4A) 抑制剂。Didesmethylrocaglamide 具有有效的生长抑制活性,IC50 为 5 nM。Didesmethylrocaglamide 抑制多种促进生长的信号通路,并诱导肿瘤细胞凋亡 (apoptosis)。抗肿瘤活性。
  41. GC39798 Scoulerine

    金黄紫堇碱,(-)-Scoulerine; Discretamine

    A benzylisoquinoline alkaloid with diverse biological activities
  42. GC39719 Nigericin

    尼日利亚霉素

    A potassium ionophore

  43. GC39708 DT2216 DT2216 是一种蛋白水解靶向嵌合体 (PROTAC),靶向 Bcl-xL 降解依赖于 Bcl-2 家族过表达蛋白(例如 Bcl-2、Bcl-xL 和 Mcl)的 T 细胞淋巴瘤-1.DT2216 抑制 G-68 细胞,IC50 值为 4.02 μM(72 小时)。
  44. GC39707 Droloxifene

    屈洛昔芬,3-Hydroxytamoxifen

    A selective estrogen receptor modulator
  45. GC39699 Aurintricarboxylic acid

    金精三羧酸

    A protein synthesis inhibitor with diverse biological activities
  46. GC39640 GPLGIAGQ TFA

    GPLGIAGQ TFA 是一种 MMP2 可切割的多肽,在脂质体和胶束纳米载体中都被用作刺激敏感的连接物,用于 MMP2 触发的肿瘤靶向治疗。GPLGIAGQ TFA可用于合成光动力治疗 (PDT) 中独特的 MMP2 靶向光敏剂。

  47. GC39620 AKOS-22 AKOS-22 是一种有效的线粒体蛋白电压依赖性阴离子通道 1 (VDAC1) 抑制剂 (Kd=15.4 μM)。AKOS-22 与 VDAC1 相互作用,抑制 VDAC1 齐聚和凋亡。AKOS-22 对线粒体功能的保护作用。
  48. GC39584 AGN194204

    IRX4204; NRX194204; VTP 194204

    AGN194204 (IRX4204) 是一种具有口服活性的,选择性 RXR 激动剂,对 RXRα,RXRβ 和 RXRγ 的 Kd 值分别为 0.4 nM,3.6 nM 和 3.8 nM,EC50 分别为 0.2 nM,0.8 nM 和 0.08 nM。AGN194204 对 RAR 无活性,并具有抗炎和抗癌作用。
  49. GC39556 CDDO-3P-Im CDDO-3P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-3P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
  50. GC39555 CDDO-2P-Im CDDO-2P-Im 是 CDDO 咪唑胺类似物,具有化学预防作用。CDDO-2P-Im 可降低小鼠肺癌模型肺肿瘤的大小和严重程度。
  51. GC39551 BRD3308 An HDAC3 inhibitor

Items 801 to 850 of 2517 total

per page

Set Descending Direction